The competition was announced today (18 July) by the Co-Chairs of the government’s dementia mission, Nadeem Sarwar and Hilary Evans, at an event hosted by the Office for Life Sciences at the Alzheimer’s Association International Conference (AAIC) in Amsterdam.

The competition is seeking organisations, including small and medium-sized enterprises, to develop and commercialise technologies that can be used as clinical tools to enable the development of transformative clinical trials and precision dementia therapies.

Dementia is a complex disease with substantial variability in how patients respond to treatments. There is an urgent need for better clinical tools that can be used to identify the right patients for the right clinical trial and the right treatment.

The application of innovations will feed in to and support the aims of the government’s Dame Barbara Windsor Dementia Mission, which is looking to realise a new generation of dementia precision therapies for the UK.

Find out more here.